Florida Blue Medicare updated its Part B Step Therapy programs for Medicare Advantage plans, effective January 1, 2026. Multiple drug categories now have new preferred and non-preferred medications, requiring step therapy trials of preferred products before non-preferred drugs can be approved.
Get alerts when payers change rules like this one
We check Florida Blue and other payers every day and email you when a change matches your specialty and state.
01Before January 1, 2026: Billing team must update prior authorization systems to reflect new step therapy requirements for all listed drug categories.
02Update billing software to flag non-preferred products requiring step therapy trials.
03Train clinical staff on new preferred drug alternatives.
04Implement workflow to verify step therapy compliance before submitting claims for non-preferred medications.
05Claims for non-preferred drugs without proper step therapy documentation will be denied.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.